SkylinePro

IBB - Biotech ETF could offer good potential

Pembelian
SkylinePro Diupdate   
NASDAQ:IBB   iShares Biotechnology ETF
IBB seems to have starting minor wave 5 up that could lead its price to the most probable target of 134.00. This sector should be be one of the good options to be in during the current market scenario. If prices crosses down 199.70, this analysis should be reviewed. FOLLOW SKYLINEPRO TO GET UPDATES.
Trading ditutup: target tercapai:
Prices reached 134.60 and should be start a correction to around the most probable target of 115.00. If prices crosses up 136, this scenario should be reviewed. See updated post

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.